作者：
Innocenti,F. [1]
;
Rez,J.R. [2]
;
Obel,J. [3]
;
Xiong,J. [4]
;
Mirkov,S. [5]
;
Chiu,Y.-L. [6]
;
Katz,D.A. [7]
;
Carr,R.A. [8]
;
Zhang,W. [9]
;
Das,S. ;
Adjei,A. ;
Moyer,A.M. ;
Chen,P.X. ;
Krivoshik,A. ;
Medina,D. ;
Gordon,G.B. ;
Ratain,M.J. ;
Sahelijo,L. ;
Weinshilboum,R.M. ;
Fleming,G.F. ;
Bhathena,A.
作者单位：
AbbVie Inc, North Chicago, United States
[1]
Eshelman School of Pharmacy, Lineberger Comprehensive Cancer Center, University of North Carolina
[2]
Department of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, United States, Department of
[3]
Department of Medicine, United States
[4]
Department of Medicine, United States, Committee on Pharmacology and Pharmacogenomics, United
[5]
Committee on Pharmacology and Pharmacogenomics, United States, Department of Human Genetics
[6]
Department of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, United States
[7]
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, United
[8]
Department of Medicine, United States, University of Chicago Comprehensive Cancer Center, United
[9]
发布时间
2013-11-20
换一批
换一批
